Michael Baum

21.8k total citations · 8 hit papers
283 papers, 13.3k citations indexed

About

Michael Baum is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Michael Baum has authored 283 papers receiving a total of 13.3k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Oncology, 111 papers in Cancer Research and 80 papers in Genetics. Recurrent topics in Michael Baum's work include Breast Cancer Treatment Studies (103 papers), Estrogen and related hormone effects (58 papers) and Global Cancer Incidence and Screening (31 papers). Michael Baum is often cited by papers focused on Breast Cancer Treatment Studies (103 papers), Estrogen and related hormone effects (58 papers) and Global Cancer Incidence and Screening (31 papers). Michael Baum collaborates with scholars based in United Kingdom, United States and Germany. Michael Baum's co-authors include Jack Cuzick, Lesley Fallowfield, Mitch Dowsett, Anthony Howell, G. P. Maguire, J. Houghton, Aman U. Buzdar, John Forbes, Angela Hall and Romano Demicheli and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Michael Baum

273 papers receiving 12.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

2010 1.1k citations Jack Cuzick, Ivana Šestak et al. profile →
Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy.

1994 693 citations Jack Cuzick, J. Houghton et al. Journal of Clinical Oncology profile →
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early‐stage breast cancer

2003 665 citations Michael Baum Cancer profile →
Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial.

1990 619 citations Lesley Fallowfield, Angela Hall et al. BMJ profile →
Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen

2009 581 citations Mitch Dowsett, Jack Cuzick et al. Journal of Clinical Oncology profile →
Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study

2010 546 citations Mitch Dowsett, Jack Cuzick et al. Journal of Clinical Oncology profile →
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial

2002 533 citations Michael Baum, Anthony Howell et al. profile →
Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib

2011 446 citations Michael Baum et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Baum United Kingdom	53	6.3k	5.8k	3.5k	2.5k	2.2k	283	13.3k
Judith M. Bliss United Kingdom	56	6.9k 1.1×	5.0k 0.9×	1.9k 0.5×	3.3k 1.3×	1.6k 0.7×	281	13.8k
Roger A’Hern United Kingdom	75	9.4k 1.5×	5.4k 0.9×	2.5k 0.7×	5.2k 2.1×	3.7k 1.7×	282	20.5k
Henning T. Mouridsen Denmark	57	8.0k 1.3×	6.7k 1.2×	2.5k 0.7×	3.6k 1.4×	1.6k 0.7×	243	14.1k
Sharon H. Giordano United States	76	10.8k 1.7×	7.4k 1.3×	3.3k 0.9×	4.1k 1.6×	2.2k 1.0×	408	20.8k
Rosalind A. Eeles United Kingdom	70	5.7k 0.9×	3.9k 0.7×	7.0k 2.0×	4.7k 1.9×	5.8k 2.6×	361	17.7k
Hoda Anton‐Culver United States	61	4.7k 0.7×	2.2k 0.4×	2.4k 0.7×	1.7k 0.7×	2.0k 0.9×	265	12.1k
Phyllis A. Wingo United States	52	9.4k 1.5×	2.7k 0.5×	2.3k 0.7×	4.9k 2.0×	4.2k 1.9×	105	20.8k
Hyman B. Muss United States	84	17.2k 2.7×	9.4k 1.6×	3.6k 1.0×	5.7k 2.3×	2.9k 1.3×	556	29.7k
Kathleen I. Pritchard Canada	72	15.6k 2.5×	9.9k 1.7×	5.0k 1.4×	5.4k 2.1×	6.1k 2.7×	369	25.4k
Peter A. Fasching Germany	55	8.0k 1.3×	6.7k 1.2×	1.3k 0.4×	3.0k 1.2×	3.1k 1.4×	614	14.6k

Countries citing papers authored by Michael Baum

Since Specialization

Citations

This map shows the geographic impact of Michael Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Baum more than expected).

Fields of papers citing papers by Michael Baum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Baum. The network helps show where Michael Baum may publish in the future.

Co-authorship network of co-authors of Michael Baum

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Baum. A scholar is included among the top collaborators of Michael Baum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Baum. Michael Baum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baum, Michael. (2018). Der Widerstand gegen Literatur. 1 indexed citations

Corica, Tammy, Anna K. Nowak, Max Bulsara, et al.. (2016). Cosmesis and breast-related quality of life outcomes following intra-operative radiotherapy for early breast cancer - a sub-study of the TARGIT - a trial. UCL Discovery (University College London). 2 indexed citations

Retsky, Michael, Rick A. Rogers, Romano Demicheli, et al.. (2012). NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup. Breast Cancer Research and Treatment. 134(2). 881–888. 83 indexed citations

Ring, Alistair, Ivana Šestak, Michael Baum, et al.. (2011). Influence of Comorbidities and Age on Risk of Death Without Recurrence: A Retrospective Analysis of the Arimidex, Tamoxifen Alone or in Combination Trial. Journal of Clinical Oncology. 29(32). 4266–4272. 50 indexed citations

Hackshaw, Allan, Sy Ha, Sharon Forsyth, et al.. (2011). Long-Term Benefits of 5 Years of Tamoxifen: 10-Year Follow-Up of a Large Randomized Trial in Women at Least 50 Years of Age With Early Breast Cancer. Journal of Clinical Oncology. 29(13). 1657–1663. 68 indexed citations

Dowsett, Mitch, Jack Cuzick, J. N. Ingle, et al.. (2009). Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen. Journal of Clinical Oncology. 28(3). 509–518. 581 indexed citations breakdown →

Baum, Michael & Edzard Ernst. (2009). Should We Maintain an Open Mind about Homeopathy?. The American Journal of Medicine. 122(11). 973–974. 17 indexed citations

Klimek, Virginia M., P. Maslak, Ilhem Guernah, et al.. (2008). Tolerability, Pharmacodynamics, and Pharmacokinetics Studies of Depsipeptide (Romidepsin) in Patients with Acute Myelogenous Leukemia or Advanced Myelodysplastic Syndromes. Clinical Cancer Research. 14(3). 826–832. 113 indexed citations

Fønnebø, Vinjar & Michael Baum. (2007). NHS Letter Stimulates International Dialogue on Interpretation and Possible Implications of CAM Research. The Journal of Alternative and Complementary Medicine. 13(3). 311–316. 2 indexed citations

10.

McMenamin, M., Helen Barry, Anne Marie Lennon, et al.. (2005). A survey of breast cancer awareness and knowledge in a Western population: lots of light but little illumination. European Journal of Cancer. 41(3). 393–397. 72 indexed citations

11.

Baum, Michael. (2003). Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early‐stage breast cancer. Cancer. 98(9). 1802–1810. 665 indexed citations breakdown →

12.

Vaidya, Jayant S., et al.. (2001). Targeted intra-operative radiotherapy (Targit): An innovative method of treatment for early breast cancer. Annals of Oncology. 12(8). 1075–1080. 169 indexed citations

13.

Marsden, Jo, Michael Baum, Roger A’Hern, et al.. (2001). The impact of hormone replacement therapy on breast cancer patients' quality of life and sexuality: a pilot study. The Journal of the British Menopause Society. 7(2). 85–91. 6 indexed citations

14.

Vaidya, Jayant S., Michael Baum, J. Houghton, et al.. (2001). Targeted intraoperative radiotherapy for breast cancer - a randomised trial. UCL Discovery (University College London). 3 indexed citations

15.

Baum, Michael, et al.. (1994). Breast cancer : a guide every woman. Oxford University Press eBooks. 10 indexed citations

16.

Jatoi, Ismail & Michael Baum. (1993). American and European recommendations for screening mammography in younger women: a cultural divide?. BMJ. 307(6917). 1481–1483. 18 indexed citations

17.

Dobbs, H.J., et al.. (1993). Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life. British Journal of Cancer. 67(2). 402–406. 36 indexed citations

18.

Fallowfield, Lesley, Angela Hall, G. P. Maguire, & Michael Baum. (1990). Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial.. BMJ. 301(6752). 575–580. 619 indexed citations breakdown →

19.

Baum, Michael. (1981). Breast cancer trials—a new initiative. BMJ. 282(6263). 563.3–564. 1 indexed citations

20.

Magarey, Christopher J. & Michael Baum. (1971). Oestrogen as a Reticuloendothelial Stimulant in Patients with Cancer. BMJ. 2(5758). 367–370. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact